No statistical evaluation of patients with carcinoid syndrome in a reliable
number of cases has been available in the past 35 years. To update our kno
wledge about the syndrome, we have evaluated from various clinicopathologic
viewpoints a large series of patients with the syndrome reported up to dat
e.
The data of 748 patients with the syndrome were collected from 8876 carcino
id patients reported in the literature and analyzed by the Gut-Pancreatic E
ndocrinoma Analyzing System (the Niigata Registry). The results are summari
zed as follows. 1)The patients with the syndrome had a tendency to be older
than those without it. 2) The incidence of the syndrome was 8.4% of 8876 c
arcinoid patients. 3) Serotonin activities were extremely high in patients
with the syndrome as compared to those without it (91.7% versus 26.6%). 4)
The rate of metastases was higher in patients with the syndrome than in tho
se without it (84.8% versus 29.2%), and higher in the liver than in lymph n
odes among patients with the syndrome (73.4% versus 37.4%). 5) Flushing and
carcinoid heart as most specific clinical manifestations of the syndrome w
ere recorded at 78.3% and 17.4%, respectively. 6) The 5-year survival rate
after resection of primary lesions was 76.0% of 304 patients with the syndr
ome, lower in patients with digestive carcinoids than in those with extradi
gestive lesions (67.2% versus 88.7%).
It is expected that the results obtained in the present evaluation on patie
nts with carcinoid syndrome will provide investigators active in this speci
alized field with useful and extensive information for their future activit
ies.